- Report
- May 2024
- 140 Pages
Global
From €5907EUR$6,499USD£5,058GBP
- Report
- June 2024
- 200 Pages
Global
From €7226EUR$7,950USD£6,187GBP
- Report
- May 2022
- 41 Pages
Global
From €1818EUR$2,000USD£1,557GBP
The Hypertrophic Scar Drug market is a subset of the Dermatological Drugs market, which focuses on the treatment of skin conditions. Hypertrophic scar drugs are used to reduce the appearance of raised, red, and thickened scars, which are often caused by burns, surgery, or other skin trauma. These drugs are typically administered topically, and may contain ingredients such as silicone, onion extract, and vitamin E. In some cases, steroid injections may be used to reduce the appearance of hypertrophic scars.
The Hypertrophic Scar Drug market is highly competitive, with many companies offering products to treat these scars. Some of the major players in the market include Smith & Nephew, Allergan, Merz, and Biodermis. Show Less Read more